Immune cells promote or prevent cytomegalovirus activity in mice depending on location

August 10, 2017
Treg have divergent control of MCMV infection depending upon the issue. In the spleen, Treg antagonize CD8+ effector function and promote viral persistence while in the salivary gland Treg prevent IL-10 production from Foxp3 - CD4+ T cells and limit viral reactivation and replication. Credit: Almana, et al. (2017)

Immune system cells called regulatory T cells appear to promote cytomegalovirus (CMV) latency in the spleen of mice, but suppress it in the salivary gland. Maha Almanan of the University of Cincinnati College of Medicine, Cincinnati Children's Hospital Research Foundation, and colleagues present this surprising finding in a new study in PLOS Pathogens.

CMV infects over half of adults by the time they reach the age of 40. Usually, it causes no signs or symptoms, but it can be dangerous for people with weakened immune systems and for babies who contract it before birth. In most people, CMV settles into a latent state; its genome exists in the cells of the infected person, but it does not replicate or cause harm unless it is reactivated.

Previous work has shown that known as regulatory T cells are associated with reactivation of CMV in immune suppressed patients. Whether or not regulatory T cells were causal in this context was unclear. In the new study, the research team investigated this role in mice by infecting them with a mouse version of CMV.

Eight months after infection, CMV had established latent infection of the spleen, salivary gland, lung, and pancreas. The mice were of a recently developed strain that allowed the researchers to then trigger a decrease in levels of regulatory T cells and examine the effects.

The results suggest that regulatory T cells can either suppress or reactivate latent CMV depending on where in the body they are acting. In the spleen, depletion of regulatory T cells reduced viral load and enhanced the functionality of whose job is to eliminate viruses. But opposite effects occurred in the salivary gland, suggesting that regulatory T cells normally prevent CMV reactivation and replication in the .

Future work could explore whether these findings hold true in humans and why regulatory T cells have opposing effects in different mouse tissues. Better understanding of the role of regulatory T cells could aid development of treatments that manipulate their activity. Such treatments may hold particular promise for preventing CMV reactivation in patients with suppressed immune systems (eg those with HIV or organ-transplants), and are already being investigated in such patients.

Explore further: Study reveals how to reprogram cells in our immune system

More information: Almanan M, Raynor J, Sholl A, Wang M, Chougnet C, Cardin RD, et al. (2017) Tissue-specific control of latent CMV reactivation by regulatory T cells. PLoS Pathog 13(8): e1006507. doi.org/10.1371/journal.ppat.1006507

Related Stories

Study reveals how to reprogram cells in our immune system

August 2, 2017
When the immune system is imbalanced, either due to overly-active cells or cells that suppress its function, it causes a wide range of diseases, from psoriasis to cancer. By manipulating the function of certain immune cells, ...

Immune cells may be key to better allergy, infection therapies

July 28, 2017
By learning how a recently discovered immune cell works in the body, researchers hope to one day harness the cells to better treat allergies and infections, according to new Cornell research.

Rebuilding the salivary gland after radiation

January 12, 2017
Patients who undergo radiation therapy for head and neck cancers often lose the ability to produce saliva because radiation destroys salivary glands that lie in the way of the tumor.

Treating the inflammation in lymphedema

October 11, 2016
ETH researchers have discovered that certain cells in the immune system suppress the development of lymphedema. Anti-inflammatory therapies could therefore be the key to treating this previously incurable condition.

Promoting regulatory T cell production may help control atherosclerosis

August 2, 2016
In atherosclerosis, the buildup of cholesterol deposits in arteries poses a major risk for cardiovascular diseases like heart attack and stroke. As cholesterol accumulates, it triggers an inflammatory response that recruits ...

Critical immunotherapy target marks dysfunctional regulatory T cells in brain cancer

April 21, 2016
Immunotherapy represents an exciting advance in cancer treatment that harnesses the immune system to seek and destroy cancer cells. The programmed death 1 (PD-1) pathway dampens immune responses to tumor cells, and several ...

Recommended for you

Australian researchers in peanut allergy breakthrough

August 17, 2017
Australian researchers have reported a major breakthrough in the relief of deadly peanut allergy with the discovery of a long-lasting treatment they say offers hope that a cure will soon be possible.

Genetic variants found to play key role in human immune system

August 16, 2017
It is widely recognized that people respond differently to infections. This can partially be explained by genetics, shows a new study published today in Nature Communications by an international collaboration of researchers ...

Study identifies a new way to prevent a deadly fungal infection spreading to the brain

August 16, 2017
Research led by the University of Birmingham has discovered a way to stop a deadly fungus from 'hijacking' the body's immune system and spreading to the brain.

Biophysics explains how immune cells kill bacteria

August 16, 2017
(Tokyo, August 16) A new data analysis technique, moving subtrajectory analysis, designed by researchers at Tokyo Institute of Technology, defines the dynamics and kinetics of key molecules in the immune response to an infection. ...

How a nutrient, glutamine, can control gene programs in cells

August 15, 2017
The 200 different types of cells in the body all start with the same DNA genome. To differentiate into families of bone cells, muscle cells, blood cells, neurons and the rest, differing gene programs have to be turned on ...

Scientists identify gene that controls immune response to chronic viral infections

August 15, 2017
For nearly 20 years, Tatyana Golovkina, PhD, a microbiologist, geneticist and immunologist at the University of Chicago, has been working on a particularly thorny problem: Why are some people and animals able to fend off ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.